Literature DB >> 18033060

[Malassezia folliculitis: characteristics and therapeutic response in 26 patients].

A Lévy1, M Feuilhade de Chauvin, L Dubertret, P Morel, B Flageul.   

Abstract

BACKGROUND: Malassezia folliculitis is most often described in patients living in hot and humid countries or in immunocompromised patients. Its frequency in France is unknown. We report 26 cases diagnosed at Saint-Louis Hospital between May 2002 and April 2004. The clinical features, the contributing factors, the results of direct mycological examination and/or histology and the efficacy of antifungal treatments were compared to the literature. PATIENTS AND METHODS: The inclusion criteria were the presence of folliculitis on the trunk confirmed by direct microscopy and/or histopathology showing abundant yeast cells in the follicles.
RESULTS: Patients comprised 22 men and 4 women (M/F sex ratio: 5: 5) with a mean age of 46 years. Five patients (19%) were immunocompromised. In normal patients, the duration of folliculitis was long with a mean of 61 months. The eruption was typical, with follicular papules and superficial pustules distributed predominantly on the trunk. Itching was frequent (70%). Direct microscopy was more often positive than histology (89% vs 33%). Some sixty-five percent of the patients had been previously treated by topical or systemic antibiotics or anti-acne drugs, which was ineffective in all cases. Cure with topical ketoconazole, oral ketoconazole alone or in combination with topical ketoconazole occurred respectively in 12%, 75% and 75% of patients, but with consistent recurrence within 3 to 4 months after cessation of treatment. DISCUSSION: Malassezia folliculitis is probably misdiagnosed, as suggested by the long time between onset and diagnosis and the high frequency of non-antifungal treatments prescribed. In our study, direct mycological examination provided more effective diagnosis than histology. Treatment is difficult especially because of the high frequency of relapses.
CONCLUSION: A diagnosis of Malassezia folliculitis should be considered in young adults or immunocompromised patients with an itching follicular eruption. Further therapeutic trials are needed due to the frequency of relapse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18033060     DOI: 10.1016/s0151-9638(07)92824-0

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  7 in total

1.  Comparison between Malassezia Folliculitis and Non-Malassezia Folliculitis.

Authors:  Hyo Sang Song; Sue Kyung Kim; You Chan Kim
Journal:  Ann Dermatol       Date:  2014-09-26       Impact factor: 1.444

2.  Malassezia folliculitis in an infant.

Authors:  S Anane; O Chtourou; C Bodemer; M Kharfi
Journal:  Med Mycol Case Rep       Date:  2013-03-01

3.  Malassezia (Pityrosporum) Folliculitis Masquerading As Recalcitrant Acne.

Authors:  Vikas Malgotra; Harjap Singh
Journal:  Cureus       Date:  2021-02-24

Review 4.  Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals.

Authors:  Stefan Hobi; Claudia Cafarchia; Valentina Romano; Vanessa R Barrs
Journal:  J Fungi (Basel)       Date:  2022-07-04

Review 5.  Malassezia-Can it be Ignored?

Authors:  Ambujavalli Balakrishnan Thayikkannu; Anupma Jyoti Kindo; Mahalakshmi Veeraraghavan
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

Review 6.  Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment.

Authors:  Ditte M L Saunte; George Gaitanis; Roderick James Hay
Journal:  Front Cell Infect Microbiol       Date:  2020-03-20       Impact factor: 5.293

Review 7.  The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions.

Authors:  Samantha R Ellis; Mimi Nguyen; Alexandra R Vaughn; Manisha Notay; Waqas A Burney; Simran Sandhu; Raja K Sivamani
Journal:  Microorganisms       Date:  2019-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.